Athyrium Provides $110MM Facility to Kala Pharmaceuticals
Kala Pharmaceuticals closed a $110 million credit facility with funds managed by Athyrium Capital Management. Morgan Stanley acted as sole structuring agent on the transaction.
Read moreDetails









